Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of ChAdOx1 Covid-19 vaccine in Thai people with underlying disease
TCTR20211228003Phase 4Completed
- Sponsor
- Chulabhorn Royal Academy
- Start
- Jun 2021
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Chulabhorn Royal Academy. Started Jun 2021; status: completed.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211228003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211228003.